gilteritinib
astellas pharmaceuticals
[]
wow! giovanni martinelli announced very interesting results on differentiation effects of gilteretinib (flt3i) that will be presented at presidential symposium on saturday #eha2022. thrilled!
PhD #AML #drugresistance #epigenetics #bloodcancer @Young_EHA Ambassador; @EACRnews ambassador. Tweets are my own.